1. Home
  2. PMI vs PROF Comparison

PMI vs PROF Comparison

Compare PMI & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PMI

Picard Medical Inc.

N/A

Current Price

$1.80

Market Cap

202.7M

Sector

N/A

ML Signal

N/A

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$7.33

Market Cap

230.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMI
PROF
Founded
1981
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
202.7M
230.4M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
PMI
PROF
Price
$1.80
$7.33
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
184.6K
240.4K
Earning Date
03-20-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,767,000.00
$14,297,000.00
Revenue This Year
N/A
$64.23
Revenue Next Year
N/A
$113.06
P/E Ratio
N/A
N/A
Revenue Growth
8.81
67.94
52 Week Low
$1.58
$3.76
52 Week High
$13.68
$8.95

Technical Indicators

Market Signals
Indicator
PMI
PROF
Relative Strength Index (RSI) 43.35 43.83
Support Level $1.74 $7.40
Resistance Level $1.89 $8.15
Average True Range (ATR) 0.13 0.55
MACD 0.06 -0.12
Stochastic Oscillator 50.00 5.09

Price Performance

Historical Comparison
PMI
PROF

About PMI Picard Medical Inc.

Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: